tiprankstipranks
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market

Dianthus Therapeutics (DNTH) Income Statement

Compare
310 Followers

Dianthus Therapeutics Income Statement

Last quarter (Q3 2024), Dianthus Therapeutics's total revenue was $2.17M, an increase of 135.06% from the same quarter last year. In Q3, Dianthus Therapeutics's net income was $-25.17M. See Dianthus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.83M$ 6.42M$ 1.48M$ 0.00$ 0.00
Gross Profit
$ 2.47M$ 6.27M$ -544.00K$ -1.98M$ -1.84M
Operating Expenses
$ 51.00M$ 36.12M$ 14.56M$ 76.72M$ 81.13M
Depreciation and Amortization
$ 355.00K$ 147.00K$ 2.02M$ 1.98M$ 1.84M
EBITDA
$ -48.17M$ -29.56M$ -13.09M$ -72.96M$ -74.93M
Operating Income
$ -48.17M$ -29.70M$ -13.09M$ -78.70M$ -82.97M
Other Income/Expenses
$ 4.62M$ 1.23M$ -23.00K$ 3.77M$ 6.20M
Pretax Income
$ -43.55M$ -28.48M$ -13.11M$ -74.94M$ -76.77M
Net Income
$ -43.55M$ -28.48M$ -13.11M$ -74.94M$ -76.77M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -8.45$ -7.60$ -3.82$ -27.30$ -33.18
Diluted EPS
$ -8.45$ -7.60$ -3.82$ -27.30$ -33.18
Weighted Average Shares Outstanding
5.15M 3.75M 3.43M 2.75M 2.31M
Weighted Average Shares Outstanding (Diluted)
5.15M 3.75M 3.43M 2.75M 2.31M
Currency in USD

Dianthus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis